EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis

Yuan Gao, Jianlei Liu, Benjamin Gong, Jianyuan Pei, Xiwei Zhuang, Chijia Zeng, Hangrui Zhang, Emmanuel Agu, Yanling Wang, Zhihao Duan, Kunyang Xue, Qin Zhou und 1 weitere

Biosensors and Bioelectronics · 2026-10 · 310 · 118863

DOI: 10.1016/j.bios.2026.118863 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors and Bioelectronics, 2026-10. Verfasst von Yuan Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Biosensing Techniques, Communicable Diseases, Glycomics. Die Arbeit nennt 234 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycans mediate microbial adhesion, host-cell entry, immune recognition and immune evasion, but their branching topology, linkage isomerism and context-dependent functions make glycan-centered infectious-disease research difficult to standardize. This review summarizes how artificial intelligence (AI), machine learning (ML) and deep learning (DL) are being applied to glycomics and glycoanalysis in infection biology. We first outline major sample sources, analytical platforms and curated databases used to generate glycan data, including mass spectrometry (MS), nuclear magnetic resonance (NMR), chromatography and glycan/lectin microarrays. We then compare supervised learning, unsupervised learning, graph neural networks(GNNs), sequence models and transformer-informed frameworks for glycan structure analysis, lectin-glycan binding prediction, pathogenicity assessment and biomarker discovery. Representative validated models, including SweetNet and LectinOracle, demonstrate that glycan-aware AI can achieve reproducible predictive performance across independent datasets. Finally, we discuss diagnostic applications, virulence forecasting, vaccine and drug development, and pathogen-related autoimmunity. Current limitations include sparse annotations, batch effects, incomplete structural coverage and limited model interpretability. Standardized datasets and interpretable multi-omics models will be essential for translating AI-driven glycoanalysis into pathogen surveillance and precision immunotherapy. In conclusion, this review summarizes how artificial intelligence (AI), machine learning (ML) and deep learning (DL) are being applied to glycomics and glycoanalysis in infection biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceBiosensing TechniquesCommunicable DiseasesGlycomicsPolysaccharidesAnimalsHumansDeep LearningGraph Neural NetworksLectinsMachine Learning

Stichwörter der Autor:innen

AI-Driven glycoanalysisGlycan bioanalysisGlycan–pathogen interactionsGlycosylationInfectious disease diagnosticsVirulence prediction

Substanzen

LectinsPolysaccharides

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China.
  • Department of Laboratory Medicine and Pathology, Foshan Fosun Chancheng Hospital, Foshan, Guangdong, 528000, China.
  • Belmont Hill School, 350 Prospect St, Belmont, MA, 02478, United States.
  • Department of Electrical and Computer Engineering, Worcester Polytechnic Institute, 100 Institute Road, MA, 01609, United States.
  • Department of Computer Science, Worcester Polytechnic Institute, 100 Institute Road, MA, 01609, United States.
  • School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China. Electronic address: zhouqin@hrbmu.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Gao, Y., Liu, J., Gong, B., Pei, J., Zhuang, X., Zeng, C., Zhang, H., Agu, E., Wang, Y., Duan, Z., Xue, K., Zhou, Q., & Cui, F. (2026). Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis. Biosensors and Bioelectronics, 310, 118863. https://doi.org/10.1016/j.bios.2026.118863

Vancouver

Gao Y, Liu J, Gong B, Pei J, Zhuang X, Zeng C, et al. Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis. Biosensors and Bioelectronics. 2026;310:118863. doi:10.1016/j.bios.2026.118863

BibTeX
@article{Gao2026,
  author = {Gao, Yuan and Liu, Jianlei and Gong, Benjamin and Pei, Jianyuan and Zhuang, Xiwei and Zeng, Chijia and Zhang, Hangrui and Agu, Emmanuel and Wang, Yanling and Duan, Zhihao and Xue, Kunyang and Zhou, Qin and Cui, Feiyun},
  title = {Sweet artificial intelligence as digital catalysts in infectious diseases: Glycomics and glycoanalysis},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {310},
  pages = {118863},
  doi = {10.1016/j.bios.2026.118863}
}
Kostenlos starten →